| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 341.3 | 313.3 |
| Gross profit | 83.7 | 72.8 |
| Profit before tax | 36.4 | 24.0 |
| Net income | 26.3 | 13.9 |
| EPS (diluted, $ a share) | $0.32 | $0.15 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Net income, year on year | +89.4% |
|---|---|
| Revenue, year on year | +8.9% |
| Gross margin | 24.5% |
| Operating margin | 10.3% |
10-Q filed with the SEC, NASDAQ: PGNY. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Progyny, Inc.: key numbers
- Share price
- $37.15Close, Nov 16
- Market cap
- $2.74B
- Shares outstanding
- 73.65MLatest SEC cover page
- Sector
- Industrial Applications and Services
- Industry
- Services-Misc Health & Allied Services, NECSIC 8090
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Progyny, Inc.
All →Progyny Chief Product Officer Geoffrey Clapp Sells $28.2K of Stock
Geoffrey Clapp, Chief Product Officer, sold 774 shares of Progyny, Inc. at $36.41 a share, worth $28.2K in total on Nov 11, 2026. Shares held after the trade: 58,235 (-1.3%).
- Value
- $28.2K
- Shares
- 774
- Price
- $36.41
- Role
- Chief Product Officer
- Holding change
- -1.3%
- Trade date
- Nov 11, 2026
Progyny CEO Peter Anevski Sells $8.48M of Stock
Peter Anevski, CEO, sold 236,630 shares of Progyny, Inc. at $35.61 to $36.29 a share (average $35.84) in 4 transactions, worth $8.48M in total on Nov 10, 2026. Shares held after the trade: 710,972 (-2.5%).
- Value
- $8.48M
- Shares
- 236,630
- Average price
- $35.84
- Role
- CEO
- Holding change
- -2.5%
- Trade date
- Nov 10, 2026
Progyny Executive Chairman David J. Schlanger Sells $1.25M of Stock
David J. Schlanger, Executive Chairman, sold 35,392 shares of Progyny, Inc. at $35.36 a share, worth $1.25M in total on Nov 10, 2026. Shares held after the trade: 238,462 (-12.9%).
- Value
- $1.25M
- Shares
- 35,392
- Price
- $35.36
- Role
- Executive Chairman
- Holding change
- -12.9%
- Trade date
- Nov 10, 2026
Progyny CEO Peter Anevski Sells $6.18M of Stock
Peter Anevski, CEO, sold 173,247 shares of Progyny, Inc. at $35.09 to $35.73 a share (average $35.68) in 4 transactions, worth $6.18M in total between Nov 5, 2026 and Nov 9, 2026. Shares held after the trade: 762,468 (-4.4%).
- Value
- $6.18M
- Shares
- 173,247
- Average price
- $35.68
- Role
- CEO
- Holding change
- -4.4%
- Trade date
- Nov 5, 2026 to Nov 9, 2026
Progyny Executive Chairman David J. Schlanger Sells $5.88M of Stock
David J. Schlanger, Executive Chairman, sold 164,608 shares of Progyny, Inc. at $35.22 to $35.73 a share (average $35.72) in 2 transactions, worth $5.88M in total between Nov 5, 2026 and Nov 9, 2026. Shares held after the trade: 238,462 (-40.3%).
- Value
- $5.88M
- Shares
- 164,608
- Average price
- $35.72
- Role
- Executive Chairman
- Holding change
- -40.3%
- Trade date
- Nov 5, 2026 to Nov 9, 2026
Progyny CFO Mark S. Livingston Sells $64.2K of Stock
Mark S. Livingston, CFO, sold 2,139 shares of Progyny, Inc. at $30.00 a share, worth $64.2K in total on Nov 4, 2026. Shares held after the trade: 70,314 (-3.0%).
- Value
- $64.2K
- Shares
- 2,139
- Price
- $30.00
- Role
- CFO
- Holding change
- -3.0%
- Trade date
- Nov 4, 2026